Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00613405 · ClinicalTrials.gov registry record · NA
Stress and Marijuana Cue-elicited Craving and Reactivity
A NA study of Cannabis Use Disorders, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
- 1
- Study location
NCT00613405: Completed NA study of Cannabis Use Disorders, sponsored by Medical University of South Carolina.
NCT00613405 is a NA study of Cannabis Use Disorders that has completed, run by Medical University of South Carolina. The registered enrollment target is 87 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00613405, a NA study of Cannabis Use Disorders, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to explore the interaction between stress and marijuana cues, in hopes that it may lead to the development of new treatments for marijuana dependence.
Primary Outcome
Defined as the score on the Marijuana Craving Questionnaire (MCQ), range 7-84, higher scores indicate more craving
Conditions Studied
Interventions
- OTHER Stress + cue exposure
- OTHER No stress + cue exposure
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-05 |
| Phase | NA |
What the finished NCT00613405 record still lists
NCT00613405 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Cannabis Use Disorders appearing as the primary indexed condition, and to 2 interventions - of which Stress + cue exposure is the first listed.
NCT00613405 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT00613405 about?
NCT00613405 is a clinical study titled "Stress and Marijuana Cue-elicited Craving and Reactivity". The purpose of this study is to explore the interaction between stress and marijuana cues, in hopes that it may lead to the development of new treatments for marijuana dependence.
What is the current status of trial NCT00613405?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2008-01. Estimated completion is 2009-05.
What conditions does trial NCT00613405 study?
This clinical trial studies the following conditions: Cannabis Use Disorders.
What interventions are being tested in trial NCT00613405?
The interventions under investigation include: Stress + cue exposure (OTHER), No stress + cue exposure (OTHER).
Who is sponsoring clinical trial NCT00613405?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00613405 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00613405's enrollment target sits among peer trials
87 974th of 2000 higher than 1,025 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia